IV Iron Administration Guidelines

Introduction to IV Iron Therapy

Routine premedication with dexamethasone is not recommended for modern IV iron formulations, as hypersensitivity reactions occur in less than 1:200,000 administrations with these agents, according to the American College of Physicians 1

Dexamethasone 8 mg IV should be administered 1 hour before IV iron infusion in patients with multiple drug allergies, as recommended by the American Academy of Allergy, Asthma, and Immunology 2, 1

For the vast majority of patients receiving modern IV iron formulations, no premedication is necessary, as stated by the American Gastroenterological Association 2, 1
Iron sucrose, ferric carboxymaltose, ferric derisomaltose, and ferumoxytol do not require test doses or routine premedication, according to the American College of Clinical Pharmacy 2, 1
The American Gastroenterological Association recommends 30-minute post-infusion observation rather than prophylactic premedication 1

If using iron dextran specifically, a mandatory 25 mg test dose must be administered as a slow IV push, waiting 1 hour before the main dose, regardless of premedication, as recommended by the American Society of Health-System Pharmacists 2, 1

True anaphylaxis is extraordinarily rare with modern formulations, according to the American Academy of Allergy, Asthma, and Immunology 1
Common symptoms typically resolve by slowing or temporarily stopping the infusion, as reported by the National Kidney Foundation 3, 4

Never administer IV iron to patients with active infection, regardless of premedication, as stated by the Infectious Diseases Society of America 2, 1

For low‑molecular‑weight iron dextran, a mandatory 25 mg test dose must be administered as a slow intravenous push, followed by a 1‑hour observation period before the full therapeutic dose. This protocol is required regardless of any premedication strategy. 5

Iron dextran is associated with a higher incidence of life‑threatening or serious acute infusion reactions (approximately 0.65 %–0.7 % of administrations) compared with newer IV iron formulations. Despite this increased risk, routine antihistamine premedication is not standard practice. [6][7]